• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲及意大利保障法定配方的规则展望

An Outlook on the European and Italian Rules to Guarantee Magistral Formulas.

作者信息

Selmin Francesca, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola

机构信息

Università degli Studi di Milano, Department of Pharmaceutical Sciences, Milano, Italy.

Farmacia Nuova Fortini, Seriate, Italy.

出版信息

Int J Pharm Compd. 2019 Jan-Feb;23(1):6-12.

PMID:30668530
Abstract

Pharmaceutical compounded medicinal preparations are aimed to fulfill the special needs of a subpopulation of patients for whom a medicinal product is not commercially available. Nowadays, this activity remains an important component of pharmacy practice and an integral part of the modern healthcare system. In 2011, the Committee of Ministers of the Council of Europe adopted a resolution to harmonize quality assurance and safety standards for medicinal products prepared in pharmacies for the special needs of patients in European countries. This article discusses the actual rules and technical norms that regulate the compounding activity in Italy in the light of the new European laws.

摘要

药物配制制剂旨在满足特定患者亚群体的特殊需求,这些患者所需的药品尚无商业供应。如今,这项活动仍是药学实践的重要组成部分,也是现代医疗保健系统不可或缺的一部分。2011年,欧洲委员会部长委员会通过了一项决议,以协调欧洲各国药房为满足患者特殊需求而配制的药品的质量保证和安全标准。本文根据欧洲新法律,探讨了意大利规范配制活动的实际规则和技术规范。

相似文献

1
An Outlook on the European and Italian Rules to Guarantee Magistral Formulas.欧洲及意大利保障法定配方的规则展望
Int J Pharm Compd. 2019 Jan-Feb;23(1):6-12.
2
Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.欧洲药品配制的监管框架及立法的实际发展情况。
Health Policy. 2014 Sep;117(3):328-33. doi: 10.1016/j.healthpol.2014.07.010. Epub 2014 Jul 18.
3
Legislation on the preparation of medicinal products in European pharmacies and the Council of Europe Resolution.欧洲药店药品制备相关立法及欧洲理事会决议。
Eur J Hosp Pharm. 2017 Jul;24(4):224-229. doi: 10.1136/ejhpharm-2016-001016. Epub 2016 Sep 5.
4
Aseptic preparation of parenteral medicinal products in healthcare establishments in Europe.欧洲医疗机构中注射用药品的无菌制备。
Eur J Hosp Pharm. 2016 Jan;23(1):50-53. doi: 10.1136/ejhpharm-2015-000709. Epub 2015 Oct 12.
5
Impact of the Council of Europe Resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients.欧洲委员会决议对药房为满足患者特殊需求而制备的药品质量和安全保证要求的影响。
Eur J Hosp Pharm. 2017 Jul;24(4):218-223. doi: 10.1136/ejhpharm-2016-001017. Epub 2016 Sep 5.
6
Council of Europe Resolution CM/Res(2016)2: a major contribution to patient safety from reconstituted injectable medicines?欧洲委员会第CM/Res(2016)2号决议:复溶注射用药品对患者安全有重大贡献?
Eur J Hosp Pharm. 2020 Jul;27(4):216-221. doi: 10.1136/ejhpharm-2018-001723. Epub 2019 Feb 16.
7
Magistral Compounding with 3D Printing: A Promising Way to Achieve Personalized Medicine.3D 打印下的药剂学调配:实现个性化医疗的有前途之路。
Ther Innov Regul Sci. 2023 Jan;57(1):26-36. doi: 10.1007/s43441-022-00436-7. Epub 2022 Aug 9.
8
The Extent of Extemporaneous Preparation and Regulatory Framework of Extemporaneous Compounding in Latvia.拉脱维亚临时制备的范围和临时配制的监管框架。
Medicina (Kaunas). 2019 Aug 26;55(9):531. doi: 10.3390/medicina55090531.
9
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
10
Pharmaceutical Compounding in Portuguese Community Pharmacies: CHARACTERIZATION AND FUTURE PERSPECTIVES.葡萄牙社区药房中的药物配制:特征与未来展望。
Int J Pharm Compd. 2016 Mar-Apr;20(2):114-22.

引用本文的文献

1
Medicine Shortages in Serbia: Pharmacists' Standpoint and Potential Solutions for a Non-EU Country.塞尔维亚的药品短缺问题:药剂师的观点及一个非欧盟国家的潜在解决方案
Pharmaceutics. 2021 Mar 26;13(4):448. doi: 10.3390/pharmaceutics13040448.